On April 5, 2022, Dr. Matthew Spear informed Poseida Therapeutics, Inc. of his intent to resign from his position as the Company's Chief Medical Officer in order to pursue another opportunity. His resignation will be effective as of April 22, 2022 and is not associated with, or attributable to, any disagreement with the Company.